Join Weave at PDDP San Diego – Lindsay Mateo Presents on AI-Driven Regulatory Innovation

We’re excited to announce that Lindsay Mateo, Chief Commercial Officer at Weave, will be speaking at the Precision Drug Discovery & Preclinical Summit (PDDP) San Diego 2025, a leading event bringing together R&D and regulatory professionals to explore cutting-edge advances in preclinical development, translational science, and digital tools. Join us in San Diego to learn how AI is transforming regulatory writing at the earliest stages of drug development.

Talk Details
Title: AI-Assisted Regulatory Writing: Findings from a Top 20 Pharma Case Study
Speaker: Lindsay Mateo, Chief Commercial Officer, Weave
Date: Thursday, October 17, 2025
Time: 2:30 PM
Location: San Diego Marriott La Jolla, La Jolla, CA
Event Website: events.precision-globe.com

Session Overview
This session presents final, unpublished findings from a real-world collaboration between Weave and a Top 20 global pharmaceutical company. The study compared traditional regulatory writing with AI-assisted drafting using data from previously submitted INDs—specifically Sections 2.6.2, 2.6.4, and 2.6.6, which are known for their analytical and narrative complexity.

The results revealed measurable time savings and improvements in quality, particularly in drafting, refinement, and data verification. The session will also introduce a practical framework for evolving regulatory processes while maintaining scientific integrity and human oversight.

Key Takeaways:

• A side-by-side comparison of human-only vs. AI-augmented drafting
• A structured framework to evaluate speed and quality
• Actionable insights for applying AI in regulatory workflows without compromising rigor

Attendees will walk away with an evidence-based view of how generative AI can support regulatory teams in early development phases without replacing scientific judgment.

Visit the Weave Booth
Stop by our exhibit table to meet the Weave team and see a live demo of The Weave Platform, our AI-native solution built to accelerate document development, structure complex data, and streamline regulatory readiness from preclinical stages onward.

Whether you're rethinking your early-stage submission strategy or exploring new digital tools to scale your team’s impact, we’d love to connect.

‍